We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
BI-EASE DUO ALLERGY (Teva Pharma Australia Pty Ltd)
Product name
BI-EASE DUO ALLERGY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
128 (255 working days)
Active ingredients
azelastine hydrochloride, fluticasone propionate
Registration type
New generic medicine
Indication
Symptomatic treatment of moderate to severe allergic rhinitis for up to 6 months